These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 38481234)

  • 1. Impact of the transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for the measurement of plasma aldosterone concentration (PAC) on the diagnosis of primary aldosteronism (PA) via retrospective analyses in Okinawa, Japan.
    Honma KI; Nakayama Y; Tamaki A; Uehara M; Teruya T; Yabiku T; Ishiki Y; Yonaha K; Chinen R; Uema T; Okamoto S; Masuzaki H
    Endocr J; 2024 Jun; ():. PubMed ID: 38910122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Characteristics of Low-renin Hypertension in a Primary Care Population.
    Shah SS; Libianto R; Gwini SM; Rusell G; Young MJ; Fuller PJ; Yang J
    J Endocr Soc; 2024 Jul; 8(8):bvae113. PubMed ID: 38957654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Aldosterone, Renin, and Aldosterone to Renin Ratio with Metabolic Profile in Primary Aldosteronism.
    Han M; Cao X; Zhang J; Yang X; Zhang Y; Liu Y
    Diabetes Metab Syndr Obes; 2024; 17():2065-2074. PubMed ID: 38778907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
    Omura M; Nishikawa T
    Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.
    Reznik Y; Amar L; Tabarin A
    Ann Endocrinol (Paris); 2016 Jul; 77(3):202-7. PubMed ID: 27318644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma aldosterone response to ACTH stimulation test for diagnosis of primary aldosteronism: a cross-sectional study.
    Manosroi W; Atthakomol P; Inthaphan P; Hintong S
    BMC Endocr Disord; 2024 Mar; 24(1):37. PubMed ID: 38481234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of midnight 1 mg dexamethasone suppression test combined with ACTH stimulation test in the diagnosis of primary aldosteronism subtypes].
    Qiu P; Zhang L; Jiang DY; Zang L; Guo QH; Lyu ZH; Mu YM
    Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(24):2242-2248. PubMed ID: 38901981
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of Different Doses of ACTH Used in ACTH Stimulation Test to Determine the Subtypes of Primary Aldosteronism].
    Qiu P; Zang L; Zhang L; Lyu Z; Mu Y; Guo Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 55(1):210-216. PubMed ID: 38322542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sparing confirmatory testing in primary aldosteronism (SCIPA): a multicenter retrospective diagnostic accuracy study.
    Ong Lopez AMC; Tiu LE; Dimayuga DC; Dampil OAC; Mendoza ES; Villa ML; Macabuag-Oliva AM
    BMC Endocr Disord; 2024 Jul; 24(1):105. PubMed ID: 38978003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
    Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
    PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary aldosteronism patients with previous cardiovascular and cerebrovascular events have high aldosterone responsiveness to ACTH stimulation.
    Nakano E; Mukai K; Fukuhara A; Otsuki M; Shimomura I; Ichijo T; Tsuiki M; Wada N; Yoneda T; Takeda Y; Oki K; Yamada T; Ogawa Y; Yabe D; Kakutani M; Sone M; Katabami T; Tanabe A; Naruse M;
    Endocr J; 2024 May; 71(5):489-497. PubMed ID: 38479860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.
    Rossi GP; Bisogni V; Bacca AV; Belfiore A; Cesari M; Concistrè A; Del Pinto R; Fabris B; Fallo F; Fava C; Ferri C; Giacchetti G; Grassi G; Letizia C; Maccario M; Mallamaci F; Maiolino G; Manfellotto D; Minuz P; Monticone S; Morganti A; Muiesan ML; Mulatero P; Negro A; Parati G; Pengo MF; Petramala L; Pizzolo F; Rizzoni D; Rossitto G; Veglio F; Seccia TM
    Int J Cardiol Hypertens; 2020 Jun; 5():100029. PubMed ID: 33447758
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.